These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3550214)

  • 1. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
    Wilcox CS; Guzman NJ; Mitch WE; Kelly RA; Maroni BJ; Souney PF; Rayment CM; Braun L; Colucci R; Loon NR
    Kidney Int; 1987 Jan; 31(1):135-41. PubMed ID: 3550214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting potassium balance during frusemide administration.
    Wilcox CS; Mitch WE; Kelly RA; Friedman PA; Souney PF; Rayment CM; Meyer TW; Skorecki KL
    Clin Sci (Lond); 1984 Aug; 67(2):195-203. PubMed ID: 6378491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of the kidney to furosemide. II. Effect of captopril on sodium balance.
    Kelly RA; Wilcox CS; Mitch WE; Meyer TW; Souney PF; Rayment CM; Friedman PA; Swartz SL
    Kidney Int; 1983 Aug; 24(2):233-9. PubMed ID: 6355617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute tolerance to furosemide. Pretreatment with captopril or prazosin does not influence diuresis and natriuresis.
    Kron BG; Sjöström PA; Karlberg BE; Odlind BG
    Scand J Urol Nephrol; 1994 Dec; 28(4):337-44. PubMed ID: 7886407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of captopril on 24-hour balances and the diurnal patterns of urinary output, blood pressure, aldosterone and atrial natriuretic peptide in conscious dogs.
    Boemke W; Palm U; Mohnhaupt R; Corea M; Seeliger E; Reinhardt HW
    Ren Physiol Biochem; 1995; 18(1):35-48. PubMed ID: 7533317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of blood pressure by the renin-angiotensin system in normal man.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Nature; 1981 May; 291(5813):329-31. PubMed ID: 7015149
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
    J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin angiotensin aldosterone system and frusemide response in congestive heart failure.
    Reed S; Greene P; Ryan T; Cerimele B; Schwertschlag U; Weinberger M; Voelker J
    Br J Clin Pharmacol; 1995 Jan; 39(1):51-7. PubMed ID: 7756099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.
    Wilcox CS; Mitch WE; Kelly RA; Skorecki K; Meyer TW; Friedman PA; Souney PF
    J Lab Clin Med; 1983 Sep; 102(3):450-8. PubMed ID: 6886524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intense angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition.
    Good JM; Brady AJ; Noormohamed FH; Oakley CM; Cleland JG
    Circulation; 1994 Jul; 90(1):220-4. PubMed ID: 8026000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover comparison of the effects of enalapril and captopril on potassium homeostasis in patients with mild hypertension.
    Ohya Y; Ueno M; Takata Y; Tominaga M; Ohmori S; Kobayashi K; Abe I; Fujishima M
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):655-9. PubMed ID: 7881704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal response to acute diuresis--a comparative study of furosemide and azosemide.
    Ogawa K; Hatano T; Yamamoto M; Matsui N
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):284-90. PubMed ID: 6378806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute administration of captopril lowers the natriuretic and diuretic response to a loop diuretic in patients with chronic cardiac failure.
    Flapan AD; Davies E; Waugh C; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1991 Aug; 12(8):924-7. PubMed ID: 1915430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
    Sharpe DN; Coxon R
    Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of captopril on urinary excretion of furosemide in hypertensive subjects.
    Fujimura A; Shimokawa Y; Ebihara A
    J Clin Pharmacol; 1990 Jun; 30(6):538-42. PubMed ID: 2191978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of captopril on renal haemodynamics and the renin-angiotensin-aldosterone and osmoregulatory systems in essential hypertension.
    Thomsen OO; Danielsen H; Sørensen SS; Pedersen EB
    Eur J Clin Pharmacol; 1986; 30(1):1-6. PubMed ID: 3519238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.